Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Newspaper Publication_Unaudited Limited Reviewed Financial Results Standalone and Consolidated_September 30, 2024
November 12, 2024
Press Release_Q2_FY 2024-25
November 12, 2024
Monitoring Agency Report_Q2_September 30, 2024
November 12, 2024
Prior Intimation of Board Meeting_November, 2024
November 5, 2024
Reconciliation of Share Capital_Sept 30, 2024
October 22, 2024
Corporate Governance Report_Sept 30, 2024
October 21, 2024
Certificate under Reg 74(5) of DP Regulation_September 30, 2024
October 14, 2024
Warning ltr_Regulation 30
September 27, 2024
Warning Letter_BSE_Reg.30
September 27, 2024
Intimation of 1st Motion App._Reg.30
September 27, 2024
Trading Window Closure_September, 2024
September 25, 2024
Investor Road Show_September 18, 2024
September 11, 2024
Intimation of NOC_STX_Merger2023
September 2, 2024
GST Order_August, 2024
August 22, 2024
Press Release_Q1_FY 2024-25
August 14, 2024
Newspaper Publication_Unaudited Financial Results_June 30, 2024
August 14, 2024
Previous
1
...
Next
6 / 36